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Abstract
As a result of the number of new high-resolution structures of the pigment and some of its photointermediates, a realistic
model for the functioning of bacteriorhodopsin seems to be finally emerging. However, lack of structural information for
some of the key functional states, and contradictions between some published structural models, argue for the use of the
synthetic approach, one that includes use of data from both crystallographic and mutagenesis studies. The role of
mutagenesis in this synthetic approach falls into two categories. First, to provide additional structural information, and
second, to test the predictions of structural models by studying mutant phenotypes. This review urges critical comparisons of
the structural and mutagenesis data, as there are problems with their selective and indiscriminate use. ß 2000 Elsevier
Science B.V. All rights reserved.
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1. Introduction
Bacteriorhodopsin (BR), the halobacterial proton
pump, is probably the most studied membrane pro-
tein. It consists of seven transmembrane helices and a
retinal chromophore covalently linked to the side
chain of K216 via a protonated Schi¡ base. Bacter-
iorhodopsin is found in halobacterial membranes in
a trimeric state, with the trimers forming two-dimen-
sional crystalline patches called the purple mem-
branes. Absorption of a photon by the chromophore
starts a cycle of reactions (so-called photocycle) that
result in proton translocation across the membrane.
The interconversions of the spectrally distinct photo-
cycle intermediates, called J, K, L, M, N, and O,
correspond to more or less understood molecular
events, including among others photoisomerization
and later thermal reisomerization of the retinal, de-
protonation and reprotonation of the Schi¡ base,
conformational changes in the protein backbone,
proton release from the extracellular surface of the
membrane and proton uptake from the cytoplasmic
side (for recent reviews see [42,57,89]).
Methodologically, one can divide the research on
BR into three periods (for a di¡erent historical sub-
division of the period of 1970^1995, see [89]). The
¢rst period encompassed about 15 years of biochem-
ical and biophysical studies of the wild-type protein.
It resulted in a substantial accumulation of basic
knowledge but did not yield su⁄cient insights to cre-
ate a realistic model for proton transport mechanism.
The ¢rst breakthrough came with introduction of
site-speci¢c mutagenesis of the protein. This started
the second period - the period of mutagenesis, which
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included about 10 years of studies of site-speci¢c
mutants and lead to the identi¢cation of the residues
that are the major players in the proton pumping. As
a result, a model of the BR functioning began to
emerge (for reviews of this period see [30,55,56]).
Still, lack of speci¢c structural information at the
atomic level left a lot of leeway in interpreting the
mutational data.
It appears that what we have been witnessing in
the last 3 years constitutes a third period: the period
of the high-resolution structures (or crystallography
period). There has been an explosive growth in the
number of BR structures, with increasing resolutions
(Table 1). Although the multitude of these structural
models yielded a lot of information toward ¢nalizing
the model of the proton transport, to fully accom-
plish this task one would need to know structures of
all the photocycle intermediates. Not all of these
structures are available at this time, even though co-
ordinates for the two intermediates (K and M) were
recently released ([31,61] and 1CWQ1). Furthermore,
some of the published structures contain contradic-
tory information about key protein groups and water
molecules involved in proton translocations
[42,60,93]. Thus, at least at the present stage of BR
research, one needs to use a synthesis of the muta-
tional and the structural data in order to make
judgements about the con£icts, and to ¢ll in the
gaps in the structural information. The two principal
questions to be asked now are whether such a syn-
thesis can succeed and what the role of mutagenesis
would be in it.
2. Problems of the synthetic approach
The success of the synthetic approach to creation
of a comprehensive model for BR would depend on
the judicious use of the vast array of mutagenesis
data2 and the novel high-resolution structures of
BR and its photointermediates. Unfortunately, nei-
ther data pools are free from problems and indis-
criminate use of the experimental information may
lead to wrong conclusions. Some of the possible pit-
falls are presented below.
2.1. Possible problems of using mutagenesis data
2.1.1. E¡ects of mutations may be overlooked or
exaggerated when mutated proteins are
expressed heterologously
At the beginning of the period of mutational stud-
ies the predominant system for expression of bacter-
io-opsin was Escherichia coli [29,63]. The process of
renaturation of the unfolded form of the expressed
protein and its reconstitution into lipid vesicles or
lipid/detergent micelles often employed an arti¢cial
lipid/detergent environment [13]. The properties of
some of the mutants obtained this way are quite
di¡erent from their equivalents expressed homolo-
gously in the halobacteria [53,70,86], many of which
are assembled in vivo into the trimeric lattice of the
native purple membrane. Some mutants are not sta-
ble in the reconstituted arti¢cial systems, and parti-
ally or fully convert either to the spectrally blue-
shifted forms known as P480 or to forms in which
the conformation of the retinal is anomalous [28].
Because of these complications, arti¢cially high shifts
of the absorption maxima, low pumping activities or
abnormal light-adaptation were reported for some of
the mutants. For example, the mutants W182F and
W189F were reported to have strongly blue-shifted
absorption spectra [41], ¢ndings not con¢rmed upon
expression of the same mutants in Halobacterium
salinarum [102]. At the same time, absence of native
lipids and disruption of BR timers in these systems
led to peculiar photocycles even in a case of the wild-
type protein expressed in E. coli (eBR). The kinetics
of M decay and proton uptake in eBR is about 10
times slower than in the purple membrane, and the
M rise is much faster [62], resembling the behavior of
purple membrane at pH as high as 10. This some-
times prevented noting important di¡erences that be-
came obvious when the mutants were expressed ho-
mologously. For example, a dramatic shift in the
Schi¡ base deprotonation equilibrium in the photo-
cycle of the V49A mutant was not reported in het-
erologous expression system [39], unlike in the same
mutant in the purple membrane [15]. It should be
1 The structure of the M intermediate, 1CWQ, was recently
released by PDB (Table 1) but it has not yet been described in
a publication.
2 Information about mutants of various proteins is available
on the web at http://pmd.ddbj.nig.ac.jp/.
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noted that kinetics of eBR and heterologously ex-
pressed BR mutants were much closer to those ob-
served in the purple membrane when high protein to
lipid ratios along with halobacterial lipids were used
for the liposomes reconstitution [1].
2.1.2. When BR mutants are used to obtain structural
information one should keep in mind that the
structure of mutants may di¡er from that of the
wild-type protein
This could happen as a result of a perturbation of
BR folding by a particular mutation, or as a result of
instability leading to partial denaturation. A more
interesting possibility, though, is that a mutation
changes the BR structure so it resembles a photo-
cycle intermediate. Examples of such changes can
be found among D85N mutants that appear to
mimic the key step in the proton transport, i.e., pro-
tonation of the retinal Schi¡ base counterion. An M-
like structure for D85N/D96N [50], as well as N-like
structure for F42C/D85N [26], were reported. Also,
the triple mutant D96G/F171C/F219L was found to
have a structure similar to that of M and N states
[92]. These observations present an opportunity for
structural insights, but pose a problem for the inter-
pretation of the photocycle intermediates in these
mutants.
There may be, in fact, a general problem with
Table 1





Sample; space group Ref. PDB reference
1BRD Electron
di¡raction
3.5 WT in purple membrane; p3 [44] Henderson et al., May 1990
2BRD Electron
di¡raction
3.5 WT in purple membrane; p3 [40] Grigorie¡ et al., Dec. 1995
1AP9 X-Ray
di¡raction
2.35 WT in lipidic cubic phase,
twinned; p63
[74] Pebay-Peyroula et al., July 1997
1AT9 Electron
di¡raction
3.0 WT in purple membrane; p3 [51] Kimura et al., Aug. 1997
1BRX X-Ray
di¡raction
2.3 WT in lipidic cubic phase,
twinned; p63
[59] Luecke et al., May 1998
1BRR X-Ray
di¡raction
2.9 WT in monoclinic crystals ; c2 [32] Essen et al., July 1998
1BM1 X-Ray
di¡raction
3.5 WT in honeycomb lattice; p622 [84] Sato et al., July 1998
2AT9 Electron
di¡raction
3.0 WT in purple membrane; p3 [65] Mitsuoka et al., Dec. 1998
1QHJ X-Ray
di¡raction
1.9 WT in lipidic cubic phase,
non-twinned; p63
[12] Belrhali et al., May 1999
1C3W X-Ray
di¡raction
1.55 WT in lipidic cubic phase,
twinned; p63
[60] Luecke et al., July 1999
1C8R X-Ray
di¡raction
1.8 D96N in lipidic cubic phase,
twinned; p63
[61] Luecke et al., July 1999
1C8S X-Ray
di¡raction
2.0 D96N in lipidic cubic phase, M state,
twinned; p63
[61] Luecke et al., July 1999
1QKO X-Ray
di¡raction
2.1 WT in lipidic cubic phase, K state,
non-twinned; p63
[31] Edman et al., July 1999
1QKP X-Ray
di¡raction
2.1 WT in lipidic cubic phase and its
K state, non-twinned; p63
[31] Edman et al., July 1999
1CWQ X-Ray
di¡raction
2.25 WT in lipidic cubic phase and its
M state, twinned; p63
Not
available
Sass et al., Aug. 1999
1QM8a X-Ray
di¡raction
? WT in honeycomb lattice; p622 Not
available
Takeda et al., Sep. 1999
aThis structure is being processed by the PDB and is not available at the moment.
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understanding the photointermediates of mutants. It
was shown, for example, that structural changes in
the M intermediate of D96G mutant are quite di¡er-
ent from those of wild type and D96N [92]. In the
case of the high-resolution M structure obtained in
D96N [61] it may be hard to deduce the pathway
connecting the Schi¡ base with its proton donor in
the wild-type BR, because the donor is replaced by
an unprotonatable group. Also, the structural infor-
mation obtained on O intermediate in L93A mutant
[91] may be not applicable to this intermediate in the
wild type because it has di¡erent retinal con¢gura-
tion [24].
2.1.3. Long-range or indirect e¡ects of some
mutations may provide misleading information
There are examples where interpreting the pheno-
types of mutants in terms of structural changes is
made very di⁄cult by long-distance e¡ects. For in-
stance, some mutations in regions far from the reti-
nal can change the spectral properties of the chro-
mophore. This seems to be the case for glutamic acid
residues in the extracellular region of the protein [81],
which probably a¡ect the chromophore through the
hydrogen-bonded network of waters and amino acid
side-chains now known to exist from X-ray di¡rac-
tion [12,60]. The presence of this network, which is
responsible for the coupling of the proton a⁄nities of
D85 and the proton releasing complex near the ex-
tracellular surface [8,78], makes the e¡ects of many
mutations in this region look very complicated. In
this way, some mutations of the residues close to
the extracellular surface (E204, E194) change the ki-
netics of M formation [25,78], even though these res-
idues are as far as 10 Aî from the site of proton
equilibration between the Schi¡ base and D85.
Also, there is an evidence that some mutations in
this region have unexpected long-range e¡ects via
changes in backbone conformation [95]. As for indi-
rect e¡ects on photocycle steps, they occur when a
mutation a¡ects a process far from the site of the
replacement by in£uencing a preceding event, which
is rate limiting. For example, an observation of
slowed proton uptake in a mutant does not necessa-
rily mean that the replaced residue was a part of the
proton pathway. It could also happen because one of
the steps coupled to the uptake is made slower, such
as: (i) the Schi¡ base reprotonation (as in D38R
[79]), (ii) retinal reisomerization (as in W182F
[100]), (iii) reversal of the conformational change
modulating the pKa of D96 (as happens upon attach-
ing bulky groups to the cysteine in T170C [17]).
2.1.4. Di¡erent replacements of the same residue can
give con£icting information
From the results of non-conservative mutations
one may misinterpret a role of the replaced residue
if a newly introduced residue perturbs the native BR
structure or forms new bonds. Replacement of the
surface aspartate D38 with arginine produced a
rather perturbed phenotype [79], implying an impor-
tant role in the proton transport for this carboxylic
acid. The conservative replacement of the same res-
idue with asparagine did not a¡ect proton pumping
[66], and produced much smaller changes in the ki-
netics of the proton transfers [18] suggesting that
D38 is not a proton donor in the photocycle. In
the same way, replacement of Y57 with asparagine
almost completely eliminated the M intermediate
[35,87], while the more conservative, but non-hydro-
gen-bonding replacement with phenylalanine had a
much milder e¡ect [35]. On the other hand, one
may use a mutation that is too conservative to reveal
a role of the residue replaced. This is probably the
case for D115, where a conservative replacement
with the hydrogen-bonding asparagine does not sig-
ni¢cantly perturb the photocycle [98], in contrast to
the greatly changed behavior of the D115L mutant
(L.S. Brown, A.K. Dioumaev, R. Needleman, J.K.
Lanyi, unpublished data), in which there must be a
complete loss of hydrogen bonding of the side-chain
to T90 [12,32,59].
2.1.5. The e¡ect of a mutation may be masked by the
compensatory action of another residue or ion
When looking at the e¡ects of some mutations one
should always explore a possibility of a compensa-
tory e¡ect of other residues or ions, which may be
able to perform some functions of a lost residue. For
example, the negative charge of D212 can be re-
placed with that of a chloride ion, which restores
the functionality of the D212N mutant in a limited
pH range [67]. It was suggested that the replacement
of a single aspartic acid on cytoplasmic surface
would not give usable information about proton
pathways, because there are several alternative routes
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for the proton conduction and other carboxylic acids
will compensate for the loss of the mutated one [51].
In later work [18], results of a simultaneous replace-
ment of the three aspartates closest to the proton
channel (D38, D36, D102) with asparagines did not
support this idea, showing no signi¢cant di¡erence
between the single and triple mutants in the kinetics
of proton uptake.
2.2. Possible problems of using crystallographic data
on BR
2.2.1. Most of the available structural information is
about the BR state
It may be unwise to go too far in using structural
information about the unphotolyzed state in order to
make conclusions about the intermediates, because
BR undergoes considerable conformational rear-
rangements during the photocycle. They include hel-
ical tilts, changes in backbone conformation, side-
chain rotations, rearrangements of water molecules,
and changes in the protonation states of the side-
chains [43,61,92].
2.2.2. It is di⁄cult to produce pure intermediate states
for structural studies, because the intermediates
are usually present as mixtures
Many of the intermediates are separated by very
small di¡erences in free energy and thus exist in equi-
libria, so it is hard to ¢nd a temperature range where
only one intermediate would be present. When illu-
mination is used to obtain certain intermediates there
is always a danger of producing their photoproducts
also, making the mixtures even more complex [6].
Some intermediates cannot be accumulated in high
concentrations even theoretically, because they can
convert back to the unphotolyzed state, thermally
or as a result of the illumination. In such cases the
composition of the photostationary states will be de-
termined by the light intensity, the decay time-con-
stant, the extinctions at the wavelength of illumina-
tion, and the quantum yields of the forward and
reverse photoreactions.
2.2.3. The obtained structures may represent just one
of a number of possible conformers stable at low
temperature
As long as cryogenic temperatures are used for the
structural data collection there will be a question if
observed structures are the same as at physiological
temperatures. This question is important for the mo-
bile extramembrane loops and tails of BR, especially
for cytoplasmic E^F loop [68,76], and for side-chains
with alternative conformations. It is well known that
spectra of many intermediates change at cryogenic
temperatures, suggesting that the same may also hap-
pen to their structures. There is an indication that
both BR and its K intermediate exist as multiple
conformers at 90 K [6]. Another example is the at-
tempt to deduce protonation states of carboxylic
acids in BR from electron di¡raction data taken at
4 K [65]. Theoretically, their proton a⁄nities could
change considerably with temperature.
2.2.4. Use of detergents for crystallization may lead to
structures di¡erent from the native ones
Solubilization of BR with detergents is a usual step
in crystallization procedure, and may lead to partial
delipidation and, as a result, to a di¡erent trimer
packing and changed conformation of the monomer.
It was shown that even sublytic concentrations of
detergents can lead to substantial loss of glycolipids
and squalenes, causing changes in the protein con-
formation and photocycle, some of which are not
fully reversible [10,69]. For the BR crystals in lipid
cubic phase, Raman and Fourier transform infrared
data argue for a functionally intact protein [43], con-
trary to earlier measurements in a di¡erent type of
BR crystals where visible spectroscopy revealed a
perturbed photocycle [85]. Also, the lattice constant
of the hexagonal two-dimensional lattice of the pur-
ple membrane is unchanged in the three-dimensional
crystals, and there is structural evidence that diphy-
tanyl lipids are retained [12,60], even though the
headgroups could not be detected. Mass spectrome-
try of extracts of these BR crystals detected four out
of six major species of lipids present [12].
2.2.5. Di¡erent ways of puri¢cation, solubilization and
crystallization may result in di¡erent structures
Various sample preparation techniques may result
in crystallographic forms with di¡erent lattices or
lipid^protein interactions and, consequently, some-
what di¡erent BR structures, especially in the loop
regions [32,68,84,93]. Some crystal forms in lipid
cubic phases demonstrated merohedral twinning,
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which, if not taken in account properly, can seriously
a¡ect the calculated structural model [103].
2.2.6. Some regions of BR structure may have low
reliability
Portions of BR are very labile, have high-temper-
ature factors, and cannot be reliably modeled from
X-ray data. This point is not always appreciated by
non-crystallographers, and can lead to overinterpre-
tation of the structural models in spite of cautionary
advice from their authors. An example is the confor-
mation of the large cytoplasmic E^F loop and the C-
terminal part of the protein, especially in the M state
[61].
3. Role of BR mutagenesis in the synthetic approach
Taking in account the above-mentioned problems,
it is possible to identify two major roles of mutagen-
esis in the synthetic approach. The ¢rst is to help to
provide additional structural information, and the
second is to ensure functional tests of the predictions
derived from structures.
3.1. Helping to provide structural information
Mutants can be used to generate stable and kineti-
cally separated photocycle intermediates for structur-
al studies. Even though the structures of the inter-
mediates in mutants may be not exactly the same as
in the wild-type BR (cf. above), they o¡er some im-
portant advantages. The changed kinetics of their
photocycles allow accumulating some intermediates
to concentrations impossible for the wild type. For
example, the structure of the M intermediate ob-
tained with wild-type BR was derived from the sam-
ples with 35% occupancy,1 while the structural data
collected with D96N mutant were from the samples
with virtually 100% occupancy [61]. Both the high-
and low-resolution structural studies took advantage
of the ability of the mutants with the Schi¡ base
proton donor D96 replaced (D96G or D96N) to ac-
cumulate large quantities of the M intermediate
[48,52,82,90,92,101]. In some cases, it was even pos-
sible to observe substates of the M intermediate us-
ing either D96N or another mutant with slow M
decay, D38R [83,92]. Some low-resolution data on
conformational changes in the N intermediate were
obtained using F219L [92,99], F171C [47], and T46V
[92] ^ the mutants with slow N decay. Published
attempts to obtain the structure of the O intermedi-
ate are limited to the low-resolution data on L93A,
the mutant with very slow O decay [91]. It should be
noted, though, that the O intermediate of this mu-
tant is di¡erent from that of the wild type, because it
has 13-cis chromophore [24,49]. Probably, high-reso-
lution structures of the late intermediates (other than
K, L, and M) will be obtained soon using other site-
speci¢c mutants.
Another important application of mutagenesis is
to create sites for labels for providing independent
structural information, which can be also used to
obtain phase information for X-ray crystallography.
One of such methods employs introduction of cys-
teines into the naturally cysteine-less BR sequence,
and derivatization of their thiol groups with labels.
Derivatization with mercuric compounds was suc-
cessfully used in X-ray di¡raction studies both for
the BR state at positions 103 [54], 27, 100, 170,
171, 222 [71], 101, 130, 160, 231 [11] and for the N
and M intermediates at positions 171 and 222, re-
spectively [47,72]. Attachment of nitroxide spin-la-
bels to cysteines allowed gaining structural informa-
tion about BR loops and helices in unphotolyzed
state using positions 72, 90, 92, 169 [2], 125^142
[3], 74, 76, 79, 82, 85, 96, 98, 101, 103, 105, 109
[38], 103, 105, 109, 113, 116, 117, 120, 124, 127,
129 [4], and 154^171 [76]. The kinetics of the struc-
tural changes in the photocycle intermediates were
followed using spin-labels with single cysteine mu-
tants at positions 72, 101, 105 [88] or at 36, 38, 46,
161 [80]. Use of double cysteine mutants S35C/
M163C and A103C/M163C [97] allowed measuring
changes in distances between the spin-labels during
the photocycle. Finally, chemical modi¢cation of in-
troduced cysteines at positions 72, 90, 92, 169 [34] or
modi¢cation with bulky compounds combined with
non-speci¢c crosslinking at positions 27, 35, 100,
156, 163, 170, 222 [17] was used to obtain structural
information. In a di¡erent approach, cysteine mu-
tants in the vicinity of retinal at positions 118, 121,
138, 141 [33] were used for the mapping of the chro-
mophore pocket by crosslinking to 4-bromoretinal.
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3.2. Providing functional information that can test
predictions from the structures for the BR state
and the photocycle intermediates
The best example of this kind of mutagenesis use is
the mechanism of the proton release from the extra-
cellular surface, a still controversial topic. According
to majority of structural models, the extracellular
region constitutes a network of the hydrogen-bonded
side-chains and water molecules. The decrease in the
pKa of the releasing group(s) follows the protonation
of D85 [8,78]. The mechanism of this long-range
coupling, and the identity of the source of the re-
leased proton have been subjects of intense investi-
gation. The several possible structures for the proton
release pathway involve various residues, and impli-
cate di¡erent mechanisms (Table 2). In this case,
mutagenesis studies are quite helpful in determining
the residues that are not essential for the normal
proton release, even though some of them may a¡ect
its kinetics. Replacement of the surface glutamates
E9 [25] or E74 (L.S. Brown, R. Needleman, J.K.
Lanyi, unpublished data), or both [104], with unpro-
tonatable residues did not a¡ect the kinetics of the
proton transfers. These data question validity of the
models implying signi¢cant role of E9 and E74 in
this process [51,74]. The proton release kinetics
were normal for the mutant T205V under physiolog-
ical conditions [59,62], even though the pKa for the
proton release was reported to be much higher than
in the wild type [58]. Mutations K129H [37], R134K
[64], S193A [58], Y83N [46] and Y83F (L.S. Brown,
R. Needleman, J.K. Lanyi, unpublished data) a¡ect
pKa of the releasing group(s) but do not abolish nor-
mal (early) release. Replacement of F208 with argi-
nine slows down the proton release without reversing
the order of the release and uptake [21], probably by
a¡ecting the pKa of the releasing group. There are
only few residues in the extracellular region (except
for the immediate members of the Schi¡ base coun-
terion, such as D85 and D212) that are indispensable
for the normal proton release, as judged from the
mutagenesis. Replacement of E204 or E194 with un-
protonatable residues blocks early proton release and
delays it until the end of the photocycle and ex-
change of these glutamates for aspartates a¡ects
the pKa and kinetics of the proton release [9,16,25].
Also, replacement of R82 with uncharged residues
(A, Q) or of its neighbor Y57 with non-hydrogen-
bonding residue (F) severely impairs the proton re-
Table 2
Structure-based models of the proton release from extracellular surface of BR
Model Participating groups Mechanism of the release and/or source of the released proton
2BRD [40] E9, Y79, R82, Y83, R134, W189,
S193, E194, E204, T205, watera
Sequence of transfers between the groups in the network (proton wire)
1AP9 [74] Water, R82, T205, E9 Delocalized proton transfer in the network
1AT9 [51] E9, E74, E194, E204, R82, watera Any of the glutamic acids may release a proton
1BRX [59] E194, E204, R82, water Water 403 is a source of the proton, which is released via E204 and E194
1BRR [32] R82, Y83, E194, E204, watera Proton is released from the E194/E204 dyad, which may be associated with
water molecule
2AT9 [65] E194, E204, R82, water Changed interaction of R82 with the glutamic acids leads to the proton
release from E204 or E194 or water molecules associated with them
1QHJ [12] E194, E204, R82, water Hydrogen-bonded network releases a proton
1C3W [60] E194, E204, R82, S193 (backbone and
side-chain), Y79 (backbone), water
Three alternative mechanisms are allowed: (i) same as in 1BRX; (ii) same




E194, E204, R82, Y83, water Displacement of R82 towards extracellular surface and rearrangement of
water molecules stabilizes anionic forms of E204 and E194 and makes
them lose the proton they share
1CWQ E194, E204, S193, R82, Y83, W189,
T205, Y79 (backbone), water
Displacement of R82 towards extracellular surface leads to its hydrogen
bonding to E204 and E194 and stabilizes their anionic forms making them
lose the proton they shareb
aThese water molecules were not observed directly, but suggested on the basis of calculated cavities in the structural model.
bThis mechanism is inferred from the coordinates, as no publication was available at the time this article was written.
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lease [5,35,73]. At the same time, there are indica-
tions that elimination of the early release is not com-
plete for the mutants R82Q [36] and Y57F (Y. Cao,
L.S. Brown, R. Needleman, J.K. Lanyi, unpublished
data) that may be consistent with the ability of glu-
tamine to form hydrogen bonds. The properties of
the mutants R82K and R82H [7,45] demonstrate al-
tered proton a⁄nities of the proton release complex,
and imply an important role for the R82 in the pro-
cess. This is consistent with the idea that movement
of R82 towards extracellular side, following protona-
tion of D85, is the cause of the proton release (Table
2). Recently, such movement was detected in high-
resolution structures of the M intermediate ([61] and
1CWQ1) and was also suggested by nuclear magnetic
resonance investigations of various mutants [75,96].
Summing up the mutagenesis data, one can sub-
stantiate deep involvement of at least three residues
suggested to be of importance by the most of the
structural models, that is, E194, E204, and R82. Still,
the problem of the source of the released proton
remains unsolved because it was impossible to detect
a reliable sign of the transient deprotonation of any
glutamic acid residue in the wild-type photocycle
[77,104]. At the same time, the transient protonation
of D194 in the photocycle of E194D mutant sug-
gested that a carboxylic acid at position 194 might
be a part of the proton releasing chain, at least in
this mutant [25]. Absence of any carboxyl deproto-
nation signal in the infrared poses a problem also for
the idea that E194/E204 dyad shares the proton that
is released [32,61].
The alternative idea, supported by the observation
of amplitude changes of a broad infrared continuum,
is that the source of the proton is a hydrogen-bonded
network of water molecules stabilized by E204, R82
and other residues [77]. Such a network, including 7^
8 water molecules, is clearly observed in the unpho-
tolyzed structures with the highest resolution [12,60],
but it is not obvious if this rather small hydrogen-
bonded cluster can be responsible for the large infra-
red continuum changes. The idea of an ice-like net-
work was supported by the large deuterium e¡ects of
the photocycle steps related to the proton release
[23]. New mutagenesis data show, however, that the
elimination of the early release by the mutations
E194Q or E204Q (or partial elimination by Y57F)
does not decrease the kinetic isotope e¡ects of these
steps, as expected, but increases them [19], pointing
to the independence of the magnitude of the deute-
rium e¡ects from the occurrence of the early release.
However, it is still possible that one of the recently
observed water molecules coordinated by some of the
three mentioned residues may be the source of the
proton.
Unlike the wealth of the functional and structural
information available about the hydrogen-bonded
network in the proton release pathway, information
about the mechanism of the reprotonation of the
Schi¡ base by D96, as well as of the proton uptake
from the cytoplasmic surface, is scanty, and these
processes are poorly understood. There are very
few hydrogen-bonded side-chains and water mole-
cules observable in the unphotolyzed state of BR in
this protein region, and a clear proton pathway can-
not be identi¢ed. This is consistent with an idea that
in the unphotolyzed state the retinal Schi¡ base and
D96 are not connected and pKa of D96 is kept very
high, and it is only in the M state that structural
changes of the protein allow D96 to become a proton
donor [20,94]. One of the two available high-resolu-
tion M structures was obtained in D96N mutant [61]
that may preclude observing the hypothetical net-
work formed by this aspartate in the M state of
the wild-type protein. Nevertheless, this structure
gives us a hint on how such pathway may be formed,
showing a rotation of the side chains of F219 and
L93 that constitute the hydrophobic barrier between
the Schi¡ base and D96. In the other high-resolution
M structure1 a water molecule connects D96 and
T46, an arrangement observed in both the BR state
and the M intermediate of the D96N mutant [61].
While hydration would probably decrease pKa of
D96 making it a suitable proton donor, one still
cannot identify the pathway of the Schi¡ base repro-
tonation from this structure. To understand the
mechanism of the subsequent reprotonation of D96
one would need to obtain the structure of the N
intermediate, which is not yet available. For these
reasons, present structure-based models of the path-
ways of deprotonation/reprotonation of D96 should
heavily rely on mutagenesis data.
It is inferred from the structural data that hydro-
phobic residues surrounding D96 (F42, I45, V49,
L93, L99, L100, L219, L223, L224) help to insulate
it and keep its pKa high [32,60,74]. Indeed, direct
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titration of the infrared band of the protonated D96
in F42C/D85N and D85N mutants demonstrated
that replacement of F42 lowers pKa of D96 by 1.5
pH units [26]. Also, the phenotypes of F219L [14],
L100C [17], and F42C (L.S. Brown, R. Needleman,
J.K. Lanyi, unpublished data) demonstrate acceler-
ated deprotonation of D96 along with its slowed
reprotonation from the surface that is consistent
with a lowered pKa. Interestingly, a similar pheno-
type is observed for the T46V mutant [17,62], where
the possibility of hydrogen-bonding of T46 and D96
side-chains [32,60] is prevented. This implicates T46
in modulation of the proton a⁄nity of D96, consis-
tent with the 0.6 Aî increase in the distance between
N96 and T46 in MN intermediate of D96N mutant
(as measured in PDB structures 1C8R and 1C8S).
Also, the disruption of the hydrogen bonding of
T46 and D96 by the intercalating water molecule
was observed in the wild-type M structure.1 Replace-
ment of several residues close to the cytoplasmic sur-
face such as D38 [18,79], R227 [14,27], and F156 [17]
slows down the reprotonation of the Schi¡ base and
accelerates reprotonation of D96, probably by in-
creasing the pKa of the D96 in a manner opposite
to that of the replacements of F42, T46, L100, or
F219. The mechanism of such a pKa increase cannot
be completely understood from the available struc-
tural data, but possibly relates to the interference of
these mutations with the conformational changes in
the M state changing the hydration of D96 [83]. As
for the residues involved in the reprotonation of the
D96, their nature has not been established reliably
either from the structure or from mutagenesis. The
idea of the involvement of surface carboxylic acids in
a ‘proton funnel’ [22,51] found some support from
the mutagenesis [79], but was questioned later upon
analysis with more conservative mutations [18] (also
cf. above).
It seems that future developments of the synthetic
approach will have to include improving the struc-
tures of the intermediates K and M, obtaining the
structures for the remaining intermediates (L, N, O),
as well as producing additional mutants deemed crit-
ical by the structural models and systematic studies
of their phenotypes. There is a question to be solved
regarding substates of the intermediates and their
structures, because on logical and in some cases ex-
perimental grounds, for each mentioned intermediate
at least two functional substates were proposed, and
for some as many as four [100]. This will require a
lot of sophistication in accumulating and identifying
the substate of interest, as many of them are not
easily distinguished spectroscopically.
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